Diversified Healthcare Trust vs Omega Healthcare Investors
DHC and OHI side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DHC and OHI compare
Omega Healthcare Investors is the larger company, worth 8.1 times as much as Diversified Healthcare Trust ($14.3B against $1.8B).
Omega Healthcare Investors grew revenue faster over the last twelve months (14.0% versus −3.8% for Diversified Healthcare Trust).
Omega Healthcare Investors keeps more of each dollar of sales as profit, with a net margin of 58.1% compared with −10.3% at Diversified Healthcare Trust.
Both pay dividends: Diversified Healthcare Trust yields 0.55% and Omega Healthcare Investors 4.3%.
Omega Healthcare Investors scores higher on the StockData Score (11 against 3 for Diversified Healthcare Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DHC | OHI |
|---|---|---|
| Size and price | ||
| Market cap | $1.8B | $14.3B |
| Share price | $7.29 | $47.05 |
| Change, 1 year | 59.5% | 7.7% |
| Change, 5 years | 129% | 61.2% |
| Beta (5Y) | 1.11 | 0.26 |
| Employees | 600 | 69 |
| StockData Score | ||
| Total score | 3 | 11 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 0 | 3 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 0 | 0 |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | – | 19.2× |
| P/S | 1.2× (better) | 10.9× |
| P/B | 1.2× (better) | 2.6× |
| EV/EBITDA | 7.3× (better) | 10.8× |
| PEG | – | 7.60 |
| Fair value | $6.41 | $47.52 |
| Margin of safety | −13.6% | 0.99% (better) |
| Growth | ||
| Revenue growth (TTM) | −3.8% | 14.0% (better) |
| Revenue growth, 5Y average | −1.2% | 5.9% (better) |
| Net income growth (TTM) | – | 41.4% |
| EPS growth (TTM) | – | 38.4% |
| EPS growth, 5Y average | – | 22.6% |
| Profitability | ||
| Net margin | −10.3% | 58.1% (better) |
| Return on equity | −9.5% | 14.5% (better) |
| Financial health | ||
| Altman Z-score | 1.08 | 2.82 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.55% | 4.3% (better) |
| Payout ratio | – | 106% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | −26.0% | 0.00% (better) |
| Buyback yield | 0.16% | – |
| Shareholder yield | 0.71% | 4.3% (better) |
| Ownership | ||
| Held by institutions | 84.9% | 81.8% |
| Held by insiders | 15.2% | 0.19% |
| Insider net buying, 12 months | $97.8K (better) | $0 |
| Short interest, % of float | – | 4.9% |
Go deeper
- DHC stock overview
- DHC income statement
- DHC valuation and score
- OHI stock overview
- OHI income statement
- OHI valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.